References
- Adashi E., Resnick C. E., Hernandez F. R., Horwitz A., Roberts C., LeRoith D., Rosenfeld R. IGF-I as an intraovarian regulator: basic and clinical implications. Ann. N. Y. Acad. Sci. 1991; 626: 161–8
- Blumenfeld Z., Dirnfeld M., Gonen Y., Abramovici H. Growth hormone co-treatment for ovulation induction may enhance conception in the co-treatment and succeeding cycles in clonidine negative but not clonidine positive patients. Hum. Reprod. 1994; 9: 209–13
- Potashnik G., Lunenfeld E., Shwartz I., Glezerman M., Roberts C. T., LeRoith D., Sharoni Y., Levy J. Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing. in vitro fertilization and embryo transfer with ovarian stimulation. Hum. Reprod. 1995; 10: 1065–9
- Owen E., Ostergaard H., Shoham Z., Jacobs H. S., Mason B. A. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in. in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil. Steril. 1991; 56: 1104–10
- Murphy L. J., Murphy L. C., Friesen H. G. Estrogen induces insulin like growth factor-I expression in the rat uterus. Mol. Endocrinol. 1987; 1: 445–50